• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The medication adherence among glaucoma patients during the coronavirus disease 2019 pandemic in Croatia.克罗地亚 2019 冠状病毒病大流行期间青光眼患者的药物依从性。
Eur J Ophthalmol. 2023 Jan;33(1):333-340. doi: 10.1177/11206721221112150. Epub 2022 Jul 5.
2
Anxiety and Treatment Adherence among Glaucoma Patients during COVID-19 Pandemic and Earthquakes in Croatia.青光眼患者在 COVID-19 大流行和克罗地亚地震期间的焦虑及治疗依从性。
Psychiatr Danub. 2022 Summer;34(2):348-355. doi: 10.24869/psyd.2022.348.
3
Personality dimensions and treatment adherence among glaucoma patients: the role of self-transcendence.青光眼患者的人格维度与治疗依从性:自我超越的作用。
Curr Med Res Opin. 2024 Apr;40(4):583-590. doi: 10.1080/03007995.2024.2323644. Epub 2024 Mar 8.
4
Evaluation of medication adherence of glaucoma patients during the COVID-19 pandemic.评估 COVID-19 大流行期间青光眼患者的药物依从性。
J Fr Ophtalmol. 2023 Jan;46(1):11-18. doi: 10.1016/j.jfo.2022.09.006. Epub 2022 Nov 17.
5
The Impact of the Coronavirus Disease 2019 Pandemic on Adherence to Ocular Hypotensive Medication in Patients with Primary Open-Angle Glaucoma.2019 年冠状病毒病大流行对原发性开角型青光眼患者眼部降压药物治疗依从性的影响。
Ophthalmology. 2022 Mar;129(3):258-266. doi: 10.1016/j.ophtha.2021.10.009. Epub 2021 Oct 19.
6
Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management.评价抗青光眼药物治疗意识和患者报告的药物依从性:青光眼管理的决定因素。
J Postgrad Med. 2023 Jul-Sep;69(3):146-152. doi: 10.4103/jpgm.jpgm_905_22.
7
[Survey of medical treatment in primary open-angle glaucoma].[原发性开角型青光眼的医学治疗调查]
J Fr Ophtalmol. 2011 Nov;34(9):624-8. doi: 10.1016/j.jfo.2011.07.009. Epub 2011 Sep 8.
8
Impact of COVID-19 on follow-up and medication adherence in patients with glaucoma in a tertiary eye care centre in south India.新型冠状病毒肺炎对印度南部一家三级眼科护理中心青光眼患者随访及药物依从性的影响。
Indian J Ophthalmol. 2021 May;69(5):1264-1270. doi: 10.4103/ijo.IJO_164_21.
9
A Survey on Patients' Opinions of Alternative Drug Delivery Systems for the Treatment of Glaucoma in South-South Nigeria.南南尼日利亚地区青光眼患者对替代药物输送系统治疗的看法调查。
Middle East Afr J Ophthalmol. 2023 Nov 21;29(4):220-225. doi: 10.4103/meajo.meajo_120_23. eCollection 2022 Oct-Dec.
10
Perspectives on Adherence to Glaucoma Medical Therapy in Brazilian Patients.巴西患者对青光眼药物治疗依从性的观点。
Pharmaceut Med. 2023 Sep;37(5):377-384. doi: 10.1007/s40290-023-00482-y. Epub 2023 Jun 8.

引用本文的文献

1
Social, personal and medical factors influencing treatment delay for patients with primary glaucoma during the COVID-19 pandemic: a qualitative interview study.新冠疫情期间影响原发性青光眼患者治疗延迟的社会、个人及医学因素:一项定性访谈研究
BMJ Open. 2025 Mar 29;15(3):e096469. doi: 10.1136/bmjopen-2024-096469.
2
Secondary Glaucoma Following Corneal Transplantation: A Comprehensive Review of Pathophysiology and Therapeutic Approaches.角膜移植术后继发性青光眼:病理生理学与治疗方法的全面综述
Cureus. 2024 Sep 21;16(9):e69882. doi: 10.7759/cureus.69882. eCollection 2024 Sep.
3
Impact of COVID-19 on glaucoma management: A review.2019冠状病毒病对青光眼治疗的影响:综述
Front Ophthalmol (Lausanne). 2022 Sep 28;2:1003653. doi: 10.3389/fopht.2022.1003653. eCollection 2022.
4
Glaucoma progression due to refraining examination amid the pandemic of COVID-19.因 COVID-19 大流行而避免检查导致的青光眼进展。
Int Ophthalmol. 2024 Apr 25;44(1):196. doi: 10.1007/s10792-024-03151-4.
5
Navigating the intersection of psychiatry and ophthalmology: A comprehensive review of depression and anxiety management in glaucoma patients.探索精神病学与眼科的交叉领域:青光眼患者抑郁和焦虑管理的全面综述
World J Psychiatry. 2024 Mar 19;14(3):362-369. doi: 10.5498/wjp.v14.i3.362.

克罗地亚 2019 冠状病毒病大流行期间青光眼患者的药物依从性。

The medication adherence among glaucoma patients during the coronavirus disease 2019 pandemic in Croatia.

机构信息

Department of Ophthalmology, Zagreb University Hospital Center, Zagreb, Croatia.

University of Zagreb, School of Medicine, Zagreb, Croatia.

出版信息

Eur J Ophthalmol. 2023 Jan;33(1):333-340. doi: 10.1177/11206721221112150. Epub 2022 Jul 5.

DOI:10.1177/11206721221112150
PMID:35791501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9260194/
Abstract

PURPOSE

This study aimed to evaluate the level of treatment adherence and identify predictors of adherence in glaucoma patients during the coronavirus disease 2019 (COVID-19) pandemic in Zagreb, Croatia.

METHODS

The cross-sectional study was conducted among primary open-angle glaucoma (POAG) patients at the Department of Ophthalmology, University Hospital Centre Zagreb, between 1st April 2020 and 1st April 2021. The sociodemographic data, clinical, and drug information were recorded. The treatment adherence was assessed through a self-administered questionnaire, the Culig Adherence Scale (CAS). Statistical analyses were performed using TIBCO Statistica™ 14.0.0.

RESULTS

113 POAG patients (48M/65F) with a mean age of 65.89 ± 8.53 years were included in this study. According to the CAS, only 39.8% of patients adhered to topical glaucoma treatment. Educational level was positively related to adherence to treatment (p = 0.022). The main predictors for adherence were the patients' positive attitude towards the drug's effect, family support, and good relationship with the healthcare providers (p < 0.05, respectively). The majority of patients stated forgetfulness as the main reason for skipping drug dosing.

CONCLUSIONS

Non-adherence to treatment was prevalent among patients with POAG during the COVID-19 pandemic in Zagreb, Croatia. Personal beliefs and attitudes towards treatment, family support, and patient-healthcare provider relationship were significant predictors of adherence. Special consideration should be given to the whole health system-level strategies targeting the adherence to treatment, especially in crises, in order to achieve positive therapeutic outcomes.The study protocol was registered in the DRKS - German Clinical Trials Register, DRKS-ID: DRKS00022081.

摘要

目的

本研究旨在评估克罗地亚萨格勒布市在 2019 年冠状病毒病(COVID-19)大流行期间青光眼患者的治疗依从水平,并确定其影响因素。

方法

这是一项横断面研究,在 2020 年 4 月 1 日至 2021 年 4 月 1 日期间,在萨格勒布大学医院眼科部门对原发性开角型青光眼(POAG)患者进行了研究。记录了患者的社会人口统计学数据、临床和药物信息。通过自我管理问卷、Culig 依从量表(CAS)评估治疗依从性。使用 TIBCO Statistica™ 14.0.0 进行统计分析。

结果

本研究共纳入 113 名 POAG 患者(48 名男性/65 名女性),平均年龄为 65.89 ± 8.53 岁。根据 CAS,只有 39.8%的患者坚持局部使用青光眼药物。教育程度与治疗依从性呈正相关(p = 0.022)。依从性的主要预测因素是患者对药物效果的积极态度、家庭支持和与医疗保健提供者的良好关系(p 值分别为 <0.05)。大多数患者表示健忘是漏服药物的主要原因。

结论

在 COVID-19 大流行期间,克罗地亚萨格勒布市的 POAG 患者普遍存在不遵医嘱治疗的情况。个人对治疗的信念和态度、家庭支持以及患者与医疗保健提供者的关系是影响治疗依从性的重要因素。在整个卫生系统层面,应特别关注针对治疗依从性的策略,尤其是在危机时期,以实现积极的治疗效果。本研究方案已在 DRKS - 德国临床试验注册中心注册,DRKS-ID:DRKS00022081。